[Aldhahi W., Hamdy O. (2003). Adipokines, inflammation, and the endothelium in diabetes. Curr. Diab. Rep., 3: 293-298.]Search in Google Scholar
[Antuna - Puente B., Feve B., Fellahi S., Bastard J.P. (2008). Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab., 34: 2-11.]Search in Google Scholar
[Baker A.R., Silva D.W., Quinn A.L., Harte D., Pagano R.S., Bonser S., Kumar P.G., Mc Ternan N.H. (2006). Human epicardial adipose tissue expressesapathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc. Diabetol., 13: 5-10.]Search in Google Scholar
[Bakker W., Eringa E.C., Sipkema P.,van Hinsbergh V.W. (2009). Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res., 335: 165-189.]Search in Google Scholar
[Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., Wang J., Rajala M.W., Pocai A., Scherer P.E., Steppan C.M., Ahima R.S., Obici S., Rossetti L., Lazar M.A. (2004). Regulation of fasted blood glucose by resistin. Science, 303: 1195-1198.]Search in Google Scholar
[Brown J.E., Onyango D.J., Dunmore S.J. (2007). Resistin down-regulates insulin receptor expression, and modulates cell viability in rodent pancreatic beta-cells. FEBS Lett., 581: 3273-3276.]Search in Google Scholar
[Chu S.W., Ding K., Li Y., Pang C., Tang C. (2008). Plasma resistin associated with myocardium injury in patients with acute coronary syndrome. Circ. J., 72: 1249-1253.]Search in Google Scholar
[Dai M.H., Xia T., Chen X.D., Gan L., Feng S.Q., Qiu H., Peng Y., Yang Z.Q. (2006). Cloning and characterization of porcine resistin gene. Domest. Anim. Endocrinol., 30: 88-97.]Search in Google Scholar
[Fantuzzi G. (2005). Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol., 115: 911-919.]Search in Google Scholar
[Fu Y., Luo L., Luo N., Garvey W.T. (2006). Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes. Nutr. Metab. (Lond)., 19: 3-28.]Search in Google Scholar
[Gao J., Chang Chua C., Chen Z., Wang H., Xu X., Hamdy R., Mc Mullen J.R., Shioi T., Izumo S., Chua B. (2007). Resistin, an adipocytokine, offers protection against acute myocardial infarction. J. Mol. Cell Cardiol., 43: 601-609.]Search in Google Scholar
[Gletsu - Miller N., Hansen J.M., Jones D.P., Go Y.M., Torres W.E., Ziegler T.R., Lin E. (2009). Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery. Obesity (Silver Spring), 17: 439-446.]Search in Google Scholar
[Hara H., Lin Y.J., Zhu X., Tai H.C., Ezzelarab M., Balamurugan A.N., Bottino R., Houser S.L., Cooper D.K. (2008). Safe induction of diabetes by high-dose streptozotocin in pigs. Pancreas., 36: 31-38.]Search in Google Scholar
[Hung H.F., Wang B.W., Chang H., Shyu K.G. (2008). The molecular regulation of resistin expression in cultured vascular smooth muscle cells under hypoxia. J. Hypertens., 26: 2349-2360.]Search in Google Scholar
[Iacobellis G., Barbaro G. (2008). The double role of epicardial adipose tissue as pro- and antiinflammatory organ. Horm. Metab. Res., 40: 442-445.]Search in Google Scholar
[Iacobellis G., Leonetti F. (2005). Epicardial adipose tissue and insulin resistance in obese subjects. J. Clin. Endocrinol. Metab., 90: 6300-6302.]Search in Google Scholar
[Iacobellis G.F., Assael M.C., Ribaudo A., Zappaterreno G., Alessi U., Di Mar-io F., Leonetti F. (2003). Epicardial fat from echocardiography:anew method for visceral adipose tissue prediction. Obes. Res., 11: 304-310.]Search in Google Scholar
[Iacobellis G.,di Gioia C.R., Cotesta D., Petramala L., Travaglini C., De San-tis V., Vitale D., Tritapepe L., Letizia C. (2009). Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels. Horm. Metab. Res., 41: 227-231.]Search in Google Scholar
[Karlsson S., Ostlund B., Myrs én- Axcrona U., Sundler F., Ahrén B. (2001). Beta cell adaptation to the dexamethasone-induced insulin resistance in rats involves increased glucose responsiveness but not glucose effectiveness. Pancreas., 22: 148-156.]Search in Google Scholar
[Karmazyn M., Purdham D.M., Rajapurohitam V., Zeidan A. (2008). Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc. Res., 79: 279-286.]Search in Google Scholar
[Kawashima J., Tsuruzoe K., Motoshima H., Shirakami A., Sakai K., Hirashi-ma Y., Toyonaga T., Araki E. (2003). Insulin down-regulates resistin m RNAthrough the synthesis of protein(s) that could accelerate the degradation of resistin m RNAin 3T3-L1 adipocytes. Diabetologia, 46: 231-240.]Search in Google Scholar
[Kim M., Oh J.K., Sakata S., Liang I., Park W., Hajjar R.J., Lebeche D. (2008). Role of resistin in cardiac contractility and hypertrophy. J. Mol. Cell Cardiol., 45: 270-280.]Search in Google Scholar
[Korah T.E., Ibrahim H.H., Badr E.A., El Shafie M.K. (2011). Serum resistin in acute myocardial infarction patients with and without diabetes mellitus. Postgrad. Med. J., 87: 463-467.]Search in Google Scholar
[Kremen J.M., Dolinkova J., Krajickova J., Blaha K., Anderlova Z., Lacinova D., Haluzikova L., Bosanska M., Vokurka S., Svacina M., Haluzik M. (2006). Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J. Clin. Endocrinol. Metab., 91: 4620-4627.]Search in Google Scholar
[Langheim S., Dreas L., Veschini L., Maisano F., Foglieni C., Ferrarello S., Sin-gara G., Zingone B., Alfieri O., Ferrero E., Maseri A., Ruotolo G. (2010). Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome. Am. J. Physiol. Heart Circ. Physiol., 298: 746-753.]Search in Google Scholar
[Lin Y., Rajala M.W., Berger J.P., Moller D.E., Barzilai N., Scherer P.E. (2001). Hyperglycemia- induced production of acute phase reactants in adipose tissue. J. Biol. Chem., 276: 42077-42083.]Search in Google Scholar
[Mariappan N., Elks C.M., Sriramula S., Guggilam A., Liu Z., Borkhsenious O., Francis J. (2010). NF-kappa B-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type IIdiabetes. Cardiovasc. Res., 85: 473-483.]Search in Google Scholar
[Mars M.,de Graaf C.,de Groot L.C., Kok F.J. (2005). Decreases in fasting leptin and insulin concentrations after acute energy restriction and subsequent compensation in food intake. Am. J. Clin. Nutr., 81: 570-577.]Search in Google Scholar
[Mazurek T., Zhang L., Zalewski A., Mannion J.D., Diehl J.T., Arafat H., Sarov- - Blat L., O ’ Brien S., Keiper E.A., Johnson A.G., Martin J., Goldstein B.J., Shi Y. (2003). Human epicardial adipose tissue isasource of inflammatory mediators. Circulation, 108: 2460-2466.]Search in Google Scholar
[Meugnier E., Faraj M., Rome S., Beauregard G., Michaut A., Pelloux V., Chias-son J.L., Laville M., Clement K., Vidal H., Rabasa - Lhoret R. (2007). Acute hyperglycemia inducesaglobal downregulation of gene expression in adipose tissue and skeletal muscle of healthy subjects. Diabetes, 56: 992-999.]Search in Google Scholar
[Miles P.D., Romeo O.M., Higo K., Cohen A., Rafaat K., Olefsky J.M. (1997). TNFalpha induced insulin resistance in vivo and its prevention by troglitazone. Diabetes, 46: 1678-1683.]Search in Google Scholar
[Mu H., Ohashi R., Yan S., Chai H., Yang H., Lin P., Yao Q., Chen C. (2006). Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc. Res., 70: 146-157.]Search in Google Scholar
[Rangwala S.M., Rich A.S., Rhoades B., Shapiro J.S., Obici S., Rossetti L., La -zar M.A. (2004). Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes, 53: 1937-1941.]Search in Google Scholar
[Sakoda H., Ogihara T., Anai M., Funaki M., Inukai K., Katagiri H., Fukushi-ma Y., Onishi Y., Ono H., Fujishiro M., Kikuchi M., Oka Y., Asano T. (2000). Dexamethasone- induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes, 49: 1700-1708.]Search in Google Scholar
[Sasayama D., Hori H., Nakamura S., Yamamoto N., Hattori K., Teraishi T., Ota M., Kunugi H. (2014). Increased protein and m RNAexpression of resistin after dexamethasone administration. Horm. Metab. Res., DOI: 10.1055/s-0034-1383651. 10.1055/s-0034-138365125011018]Search in Google Scholar
[Sato N., Kobayashi K., Inoguchi T., Sonoda N., Imamura M., Sekiguchi N., Na -kashima N., Schook L.B., Beever J.E., Roger J., Humphray S., Archibald A., Chardon P., Milan D., Rohrer G., Eversole K. (2005). Swine Genome Sequencing Consortium (SGSC):astrategic roadmap for sequencing the pig genome. Comp. Funct. Genom., 6: 251-255.]Search in Google Scholar
[Sheng C.H., Di J., Jin Y., Zhang Y.C., Wu M., Sun Y., Zhang G.Z. (2008). Resistin is expressed in human hepatocytes and induces insulin resistance. Endocrine, 33: 135-143.]Search in Google Scholar
[Shojima N., Sakoda H., Ogihara T., Fujishiro M., Katagiri H., Anai M., Onis -hi Y., Ono H., Inukai K., Abe M., Fukushima Y., Kikuchi M., Oka Y., Asano T. (2002). Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes, 51: 1737-1744.]Search in Google Scholar
[Stan D., Calin M., Manduteanu I., Pirvulescu M., Gan A.M., Butoi E.D., Simion V., Simionescu M. (2011). High glucose induces enhanced expression of resistin in human U937 monocyte-like cell line by MAPK- and NF-k B-dependent mechanisms; the modulating effect of insulin. Cell Tissue Res., 343: 379-387.]Search in Google Scholar
[Stelmanska E., Kmiec Z., Swierczynski J. (2012). The gender- and fat depot-specific regulation of leptin, resistin and adiponectin genes expression by progesterone in rat. J. Steroid. Biochem. Mol. Biol., 132: 160-167.]Search in Google Scholar
[Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A. (2001). The hormone resistin links obesity to diabetes. Nature, 409: 307-312. ]Search in Google Scholar
[van Raalte D.H., Diamant M. (2014). Steroid diabetes: from mechanism to treatment? Neth. J. Med., 72: 62-72.]Search in Google Scholar
[Yki- J ärvinen H. (2004). Insulin therapy in type 2 diabetes: role of the long-acting insulin glargine analogue. Eur. J. Clin. Invest., 34: 410-416. ]Search in Google Scholar